Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Recombinant Canine High Mobility Group Protein HMG-I/HMG-Y (HMGA1), N-His

Cat. No.AP1C17

Product TypeAnimal Proteins

Size

Product Overview

BioVenic's Recombinant Canine High Mobility Group Protein HMG-I/HMG-Y (HMGA1), N-His is a recombinant protein expressed from E.coli. Its predicted molecular weight is N/A. The purity is>97% (SDS-PAGE).

Specifications

Type Recombinant Protein
Species Canine
Expression System E.coli
Purity >97% (SDS-PAGE)
Endotoxin < 1 EU/µg
Predicted Molecular Weight N/A
Physical State Lyophilized
Formulation The buffer before lyophilization is PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

Target Information

Canine high mobility group protein HMG-I/HMG-Y are architectural transcription factors that play a role in gene regulation and chromatin structure. They act as molecular 'glue', facilitating the formation of enhanceosomes on promoter/enhancer regions of inducible genes, and are involved in diverse cellular processes including neoplastic transformation and metastatic progression.

Protein Canine High Mobility Group Protein HMG-I/HMG-Y (HMGA1)
Protein Synonym HMG-R; HMGIY; High mobility group protein A1; High mobility group protein R; High mobility group protein HMG-I/HMG-Y
Gene ID 442946
UniProt ID Q6URC2

Shipping and Storage

This product is shipped with dry ice. It is recommended to aliquote as needed and store at -80°C upon receipt. Reconstituted protein solution can be stored at 4°C for 1 week, at < -80°C for 12 months.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

User Note

  1. Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL.Aliquote the reconstituted solution to minimise freeze-thaw cycles.
Inquiry Basket